EUVIMEDDescoperă EUVIMED
Crossref

Dosimetric and biological impact of activity extravasation of radiopharmaceuticals in PET imaging

Ashok Tiwari, Matthew Andriotty, Greeshma Agasthya, John J Sunderland, Dustin R Osborne, Anuj J Kapadia

Medical Physics · 2025

DOI: 10.1002/mp.17520 ↗

At a glance

Journal article in Medical Physics, 2025. Written by Ashok Tiwari and 5 co-authors. Institution: Advanced Computing for Health Sciences, Oak Ridge National Laboratory, Oak Ridge, Tennessee, USA. Major MEDLINE topics: Positron-Emission Tomography, Radiopharmaceuticals, Extravasation of Diagnostic and Therapeutic Materials. Cited 1 times so far (Crossref); 44 references. Funded by: U.S. Department of Energy.

RezumatSubjectsDate bibliograficeCiteRelated studies

Abstract (original language)

Background

The increasing use of nuclear medicine and PET imaging has intensified scrutiny of radiotracer extravasation. To our knowledge, this topic is understudied but holds great potential for enhancing our understanding of extravasation in clinical PET imaging.

Purpose

This work aims to (1) quantify the absorbed doses from radiotracer extravasation in PET imaging, both locally at the site of extravasation and with the extravasation location as a source of exposure to bodily organs and (2) assess the biological ramifications within the injection site at the cellular level.

Methods

A radiation dosimetry simulation was performed using a whole‐body 4D Extended Cardiac‐Torso (XCAT) phantom embedded in the GATE Monte Carlo platform. A 10‐mCi dose of 18 F‐FDG was chosen to simulate a typical clinical PET scan scenario, with 10% of the activity extravasated in the antecubital fossa of the right arm of the phantom. The extravasation volume was modeled as a 5.5 mL rectangle in the hypodermal layer of skin. Absorbed dose contributions were calculated for the first two half‐lives, assuming biological clearance thereafter. Dose calculations were performed as absorbed doses at the organ and skin levels. Energy deposition was simulated both at the local extravasation site and in multiple organs of interest and converted to absorbed doses based on their respective masses. Each simulation was repeated ten times to estimate Monte Carlo uncertainties. Biological impacts on cells within the extravasated volume were evaluated by randomizing cells and exposing them to a uniform radiation source of 18 F and 68 Ga. Particle types, their energies, and direction cosines were recorded in phase space files using a separate Geant4 simulation to characterize their entry into the nucleus of the cellular volume. Subsequently, the phase space files were imported into the TOPAS‐nBio simulation to assess the extent of DNA damage, including double‐strand breaks (DSBs) and single‐strand breaks (SSBs).

Results

Organ‐level dosimetric estimations are presented for 18 F and 68 Ga radionuclides in various organs of interest. With 10% extravasation, the hypodermal layer of the skin received the highest absorbed dose of 1.32 ± 0.01 Gy for 18 F and 0.99 ± 0.01 Gy for 68 Ga. The epidermal and dermal layers received absorbed doses of 0.07 ± 0.01 Gy and 0.13 ± 0.01 Gy for 18 F, and 0.14 ± 0.01 Gy and 0.29 ± 0.01 Gy for 68 Ga, respectively. In the extravasated volume, 18 F caused an average absorbed dose per nucleus of 0.17 ± 0.01 Gy, estimated to result in 10.58 ± 0.50 DSBs and 268.11 ± 12.43 SSBs per nucleus. For 68 Ga, the absorbed dose per nucleus was 0.11 ± 0.01 Gy, leading to an estimated 6.49 ± 0.34 DSBs and 161.24 ± 8.12 SSBs per nucleus. Absorbed doses in other organs were on the order of micro‐gray (µGy).

Conclusion

The likelihood of epidermal erythema resulting from extravasation during PET imaging is low, as the simulated absorbed doses to the epidermis remain below the thresholds that trigger such effects. Moreover, the organ‐level absorbed doses were found to be clinically insignificant across various simulated organs. The minimal DNA damage at the extravasation site suggests that long‐term harm, such as radiation‐induced carcinogenesis, is highly unlikely.

Subjects

MeSH terms (MEDLINE)

Positron-Emission TomographyRadiopharmaceuticalsExtravasation of Diagnostic and Therapeutic MaterialsRadiometryPhantoms, ImagingMonte Carlo MethodHumansFluorodeoxyglucose F18

Author keywords

DNA strand breaksMonte CarloXCAT phantomabsorbed doseextravasation dosimetry

Substances

RadiopharmaceuticalsFluorodeoxyglucose F18

Authors and institutions

  • Advanced Computing for Health Sciences, Oak Ridge National Laboratory, Oak Ridge, Tennessee, USA.
  • Department of Radiation Oncology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
  • Department of Nuclear & Radiological Engineering & Medical Physics, Georgia Institute of Technology, Atlanta, Georgia, USA.
  • Department of Radiology, University of Iowa, Iowa City, Iowa, USA.
  • Department of Radiology, University of Tennessee, Knoxville, Tennessee, USA.

Funding

  • U.S. Department of Energy

Cite

APA

Tiwari, A., Andriotty, M., Agasthya, G., Sunderland, J. J., Osborne, D. R., & Kapadia, A. J. (2025). Dosimetric and biological impact of activity extravasation of radiopharmaceuticals in PET imaging. Medical Physics. https://doi.org/10.1002/mp.17520

Vancouver

Tiwari A, Andriotty M, Agasthya G, Sunderland JJ, Osborne DR, Kapadia AJ. Dosimetric and biological impact of activity extravasation of radiopharmaceuticals in PET imaging. Medical Physics. 2025. doi:10.1002/mp.17520

BibTeX
@article{Tiwari2025,
  author = {Tiwari, Ashok and Andriotty, Matthew and Agasthya, Greeshma and Sunderland, John J and Osborne, Dustin R and Kapadia, Anuj J},
  title = {Dosimetric and biological impact of activity extravasation of radiopharmaceuticals in PET imaging},
  journal = {Medical Physics},
  year = {2025},
  doi = {10.1002/mp.17520}
}
Start for free →